Shivangi Harankhedkar: Gene Therapy and CRISPR Advances in Hemoglobinopathies
Shivangi Harankhedkar, Head Department of Molecular Diagnostics and Research IMS and SUM Hospital at Siksha ‘O’ Anusandhan University, shared a post on LinkedIn:
“It was a privilege to chair the session ‘Gene Therapy and CRISPR-Based Curative Approaches in Hemoglobinopathies’, delivered by Dr Debojyoti Chakraborty, Molecular Scientist, RNA Biology Lab at CSIR – Institute of Genomics and Integrative Biology, at the CME ‘Hemoglobinopathies 2026: Challenges, Care, Cure’, organised at AlIMS Bhubaneswar on the occasion of World Sickle Cell Day.
The session provided an insightful overview of how advances in gene addition and CRISPR-based genome editing are transforming the treatment landscape of sickle cell disease-from lifelong disease control towards the possibility of durable, potentially curative therapy.
The development of BIRSA-101, India’s first indigenous CRISPR-based gene therapy for sickle cell disease, represents a landmark initiative towards making advanced genomic therapies more relevant and accessible within our own healthcare setting.
India and particularly Odisha, with its significant burden of sickle cell disease-looks forward with great hope to its clinical development and successful translation into an affordable treatment for our patients.
Grateful to the organisers, happy that I could attend this encouraging and meaningful academic programme.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering